biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	3F481BED-D2D6-4D82-BAAC-B42ACE644D94
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A3CI-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A3CI-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A3CI-01A
biospecimen__bio__biospecimen_barcode_bottom	0122967753
biospecimen__bio__day_of_creation	11
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-G3-A3CI.42613B77-F014-4AE9-AEF8-C5E632125EFA.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A3CI
biospecimen__shared__patient_id	A3CI
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	13BD28C2-4A58-4A3E-B642-1807D2A4ADD9
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	0.3
clinical__chol_lihc_shared__albumin_result_specified_value	0.4
clinical__chol_lihc_shared__albumin_result_upper_limit	0.5
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.3
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.3
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	71
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A3CI-F40231
clinical__clin_shared__bcr_followup_uuid	8C0DD4DB-2878-43B4-9417-10C388F542FC
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	1
clinical__clin_shared__platelet_result_count	186
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	05ba523b-0443-4263-b5cb-772520bf85e1
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A3CI-01A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	8379ca68-adde-41f9-9155-18609703dee0
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.81
gdc__analytes__analyte_id	a26f4740-f48f-4cc9-9130-d4e07886948d
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	b5465221-78fe-40a8-abec-bed600602dd4
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	d38463b6-1caf-5612-81fc-5a858382d91f
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1940
gdc__diagnoses__age_at_diagnosis	26224
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26224.0
gdc__diagnoses__days_to_last_follow_up	180.0
gdc__diagnoses__diagnosis_id	0858751a-24ea-5608-944d-0a09774995a4
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	35.139302233855645
gdc__exposures__exposure_id	6a20425f-9aa6-5152-9606-577e4359fb6d
gdc__exposures__height	167.0
gdc__exposures__weight	98.0
gdc__file_id	9f98efc1-6ed0-4adc-aec9-6579c5f08b73
gdc__file_name	8a66f451-5529-47a5-86ee-9ba8761739fc.mirbase21.mirnas.quantification.txt
gdc__file_size	50340
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	8356a50380a671179d7e1cae2478f015
gdc__portions__is_ffpe	false
gdc__portions__portion_id	71371508-7e36-42ff-bc45-8f5d57296998
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	258
gdc__samples__initial_weight	370.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	42613B77-F014-4AE9-AEF8-C5E632125EFA
gdc__samples__sample_id	2c1ac52f-293b-4cc1-9c90-2870cc4b14e1
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	92.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	c76d3972-3218-4550-b8db-a6643e8ea52f
gdc__submitter_id	mirna_swap_dr11_396_MirnaExpression68bf1d66-d43b-4389-bba5-827214e338a5_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	287ea99f-1ade-57e8-b11c-a94d9d8da37e
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:06:52.050+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/05ba523b-0443-4263-b5cb-772520bf85e1-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/05ba523b-0443-4263-b5cb-772520bf85e1-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129711
manually_curated__local_md5	968b07fe470ba4834bfa05f7e034ad0b
manually_curated__opengdc_download_date	2018-10-16T17:11:57.000681+02:00
manually_curated__opengdc_file_md5	e846da51087f50211523a472d4df0f58
manually_curated__opengdc_file_size	50339
manually_curated__opengdc_id	05ba523b-0443-4263-b5cb-772520bf85e1-meq
manually_curated__origin_file_size	129711
manually_curated__origin_last_modified_date	Tue Oct 16 17:21:00 CEST 2018
manually_curated__origin_md5	968b07fe470ba4834bfa05f7e034ad0b
manually_curated__tissue_status	tumoral
